Isabelle André-Schmutz

9PUBLICATIONS
190CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsHaematological tumoursImmunogenetics (incl. genetic immunology)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jan 16, 2026
Somatic deficiency of the human E3 ubiquitin ligase CBL in leukocytes impairs B cell but not T cell development and function.

Taja Vatovec, Anna-Lena Neehus, Katherine J L Jackson

|Nov 19, 2024
Dominant negative variants in ITPR3 impair T cell Ca2+ dynamics causing combined immunodeficiency.

Elena Blanco, Carme Camps, Sameer Bahal

|Apr 24, 2024
Comprehensive Genetic Profiling Reveals Frequent Alterations of Driver Genes on the X Chromosome in Extranodal NK/T-cell Lymphoma.

Yuta Ito, Amira Marouf, Yasunori Kogure

|Mar 14, 2023
A neomorphic mutation in the interferon activation domain of IRF4 causes a dominant primary immunodeficiency.

Romane Thouenon, Loïc Chentout, Nidia Moreno-Corona

|Nov 09, 2021
Transient mTOR inhibition rescues 4-1BB CAR-Tregs from tonic signal-induced dysfunction.

Baptiste Lamarthée, Armance Marchal, Soëli Charbonnier

|Feb 18, 2020
Donor-targeted serotherapy as a rescue therapy for steroid-resistant acute GVHD after HLA-mismatched kidney transplantation.

Julien Zuber, Olivia Boyer, Bénédicte Neven

Pageof 2

Frequent Collaborators

4 joint publications

Chantal Lagresle-Peyrou

4 joint publications

Marina Cavazzana

2 joint publications

P Gaudeaux

2 joint publications

Julien Zuber